Regenxbio Inc (RGNX)
Healthcare
Biotechnology
9.70 $
-4.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Regenxbio Inc (RGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -76 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -47 | -49 | -41 | -55 | -45 | -41 | -32 | 34 | -49 | -56 | -52 | -76 | -234 | |
| 4.4 | 4.4 | 4.3 | 4.2 | 4.1 | 4.0 | 4.0 | 4.0 | 3.9 | 3.9 | 3.9 | 3.9 | 16 | |
| 11 | 10 | 8.3 | 9.6 | 9.4 | 9.9 | 9.5 | 8.5 | 8.7 | 9.0 | 8.4 | 8.6 | 35 | |
| 10 | -0.6 | 9.2 | -8.2 | -4.0 | 6.1 | 12 | 16 | 7.5 | -10 | -1.8 | -1.5 | -6.1 | |
| 2.6 | 1.4 | 1.1 | 0.6 | 0.5 | 0.3 | 1.1 | 1.0 | 0.4 | 0.5 | 0.5 | 1.2 | 2.6 | |
| 55 | 39 | 34 | 13 | -0.3 | 50 | 40 | 45 | -140 | 42 | 38 | 71 | 10.0 | |
| – | 1.2 | – | 0.4 | – | 0.8 | – | 0.3 | – | 0.7 | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | – | – | |
| -9.2 | -4.8 | -12 | 121 | -9.4 | -11 | -7.7 | -5.8 | 139 | -7.1 | -9.6 | -14 | 109 | |
| -1.5 | -16 | -19 | 78 | -55 | -1.1 | 0.9 | 73 | -51 | -21 | -24 | -19 | -115 | |
| -50 | -51 | -42 | -56 | -46 | -41 | -33 | 33 | -50 | -56 | -53 | -77 | -236 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.